Multiple Repeat Prostate Biopsies and the Detection of Clinically Insignificant Cancer in Men With Large Prostates

Eugene J. Pietzak(Memorial Sloan Kettering Cancer Center), Thomas J. Guzzo(Hospital of the University of Pennsylvania), S. Bruce Malkowicz(Hospital of the University of Pennsylvania), Keith Van Arsdalen, Philip Mucksavage(Children's Hospital of Philadelphia), Alan J. Wein(University of Miami), Matthew J. Resnick(Vanderbilt University Medical Center)
Urology
June 12, 2014
10.1016/j.urology.2014.04.029
Cited by 11

Related Papers

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
|JAMA|2017|349
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268